Suppr超能文献

长期给予双硫仑对健康人体受试者中CYP1A2、CYP2C19、CYP2D6、CYP2E1和N - 乙酰转移酶活性的影响。

Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.

作者信息

Frye Reginald F, Branch Robert A

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, 807 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x.

Abstract

AIMS

Short-term disulfiram administration has been shown to selectively inhibit CYP2E1 activity but the effects of chronic disulfiram administration on the activities of drug metabolizing enzymes is unclear. The purpose of this study was to evaluate the effects of disulfiram given for 11 days on selected drug metabolizing enzyme activities.

METHODS

Seven healthy volunteers were given disulfiram 250 mg daily for 11 days. Activities of the drug metabolizing enzymes CYP1A2, CYP2C19, CYP2D6, CYP2E1 and N-acetyltransferase were determined using the probe drugs caffeine, mephenytoin, debrisoquine, chlorzoxazone, and dapsone, respectively. Chlorzoxazone was administered before disulfiram administration and after the second and eleventh doses of disulfiram, while the other probe drugs were given before disulfiram administration and after the eleventh disulfiram dose.

RESULTS

Disulfiram administration markedly inhibited chlorzoxazone 6-hydroxylation by more than 95%, but did not affect metabolism of debrisoquine or mephenytoin. Caffeine N3-demethylation was decreased by 34% (P < 0.05). Monoacetyldapsone concentrations were markedly elevated by disulfiram administration resulting in a nearly 16-fold increase in the dapsone acetylation index, calculated as the plasma concentration ratio of monoacetyldapsone to dapsone. CYP-mediated dapsone N-hydroxylation was not significantly altered.

CONCLUSIONS

These data suggest that disulfiram-mediated inhibition is predominantly selective for CYP2E1. The magnitude of CYP2E1 inhibition was similar after both acute and chronic disulfiram administration. The effects on caffeine N3-demethylation (CYP1A2) and dapsone metabolism suggest that chronic disulfiram administration may affect multiple drug metabolizing enzymes, which could potentially complicate the use of chronically administered disulfiram as a diagnostic inhibitor of CYP2E1.

摘要

目的

短期给予双硫仑已显示可选择性抑制CYP2E1活性,但长期给予双硫仑对药物代谢酶活性的影响尚不清楚。本研究的目的是评估给予双硫仑11天对选定药物代谢酶活性的影响。

方法

7名健康志愿者每天服用250mg双硫仑,共11天。分别使用探针药物咖啡因、美芬妥英、异喹胍、氯唑沙宗和氨苯砜测定药物代谢酶CYP1A2、CYP2C19、CYP2D6、CYP2E1和N-乙酰转移酶的活性。氯唑沙宗在给予双硫仑前以及给予双硫仑第二剂和第十一剂后给药,而其他探针药物在给予双硫仑前以及给予双硫仑第十一剂后给药。

结果

给予双硫仑显著抑制氯唑沙宗6-羟基化超过95%,但不影响异喹胍或美芬妥英的代谢。咖啡因N3-去甲基化降低了34%(P<0.05)。给予双硫仑后单乙酰氨苯砜浓度显著升高,导致氨苯砜乙酰化指数(以单乙酰氨苯砜与氨苯砜的血浆浓度比计算)增加近16倍。CYP介导的氨苯砜N-羟基化没有显著改变。

结论

这些数据表明双硫仑介导的抑制主要对CYP2E1具有选择性。急性和长期给予双硫仑后,CYP2E1抑制的程度相似。对咖啡因N3-去甲基化(CYP1A2)和氨苯砜代谢的影响表明,长期给予双硫仑可能会影响多种药物代谢酶,这可能会使长期使用双硫仑作为CYP2E1的诊断抑制剂变得复杂。

相似文献

2
In vivo modulation of CYP enzymes by quinidine and rifampin.
Clin Pharmacol Ther. 2000 Oct;68(4):401-11. doi: 10.1067/mcp.2000.110561.
4
Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women.
J Clin Pharmacol. 2006 Nov;46(11):1299-307. doi: 10.1177/0091270006292249.
5
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
Br J Clin Pharmacol. 1999 Dec;48(6):829-38. doi: 10.1046/j.1365-2125.1999.00099.x.
6
Validation of incorporating flurbiprofen into the Pittsburgh cocktail.
Clin Pharmacol Ther. 2006 Sep;80(3):257-63. doi: 10.1016/j.clpt.2006.06.005.
7
Assessment of cytochrome P450 activity by a five-drug cocktail approach.
Clin Pharmacol Ther. 2001 Nov;70(5):455-61. doi: 10.1067/mcp.2001.119813.
8
The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Life Sci. 2006 Nov 25;79(26):2432-40. doi: 10.1016/j.lfs.2006.08.016. Epub 2006 Aug 23.
9
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
Clin Pharmacol Ther. 2003 Mar;73(3):264-71. doi: 10.1067/mcp.2003.14.
10
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Drug Metab Dispos. 2001 Nov;29(11):1359-61.

引用本文的文献

1
Aldehyde metabolism governs resilience of mucociliary clearance to air pollution exposure.
J Clin Invest. 2025 May 15;135(14). doi: 10.1172/JCI191276. eCollection 2025 Jul 15.
2
Disulfiram-Mitigating Unintended Effects.
Antibiotics (Basel). 2023 Jan 28;12(2):262. doi: 10.3390/antibiotics12020262.
3
Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.
J Psychopharmacol. 2023 Feb;37(2):229-233. doi: 10.1177/02698811221148611. Epub 2023 Jan 26.
5
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability.
BMC Pharmacol Toxicol. 2022 Jul 22;23(1):54. doi: 10.1186/s40360-022-00583-5.
6
Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome.
NPJ Aging Mech Dis. 2020 Jul 21;6:8. doi: 10.1038/s41514-020-0046-6. eCollection 2020.
7
Disulfiram Treatment Normalizes Body Weight in Obese Mice.
Cell Metab. 2020 Aug 4;32(2):203-214.e4. doi: 10.1016/j.cmet.2020.04.019. Epub 2020 May 14.
9
Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?
Eur J Clin Pharmacol. 2018 Sep;74(9):1189-1190. doi: 10.1007/s00228-018-2481-x. Epub 2018 May 13.
10
The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects.
Eur J Clin Pharmacol. 2018 Jan;74(1):91-97. doi: 10.1007/s00228-017-2345-9. Epub 2017 Oct 5.

本文引用的文献

2
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
Br J Clin Pharmacol. 1999 Dec;48(6):829-38. doi: 10.1046/j.1365-2125.1999.00099.x.
6
Single-dose disulfiram does not inhibit CYP2A6 activity.
Clin Pharmacol Ther. 1998 Jul;64(1):39-45. doi: 10.1016/S0009-9236(98)90020-0.
7
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
J Clin Pharmacol. 1998 Jan;38(1):82-9. doi: 10.1002/j.1552-4604.1998.tb04381.x.
9
Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
J Chromatogr B Biomed Appl. 1996 Nov 15;686(2):291-6. doi: 10.1016/s0378-4347(96)00227-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验